Synonyms: Ilube® (eye drops) | N-A-C Sustain® | N-Acetyl-cysteine | N-Acetyl-L-cysteine | NAC | Parvolex®
acetylcysteine is an approved drug (FDA (1963), UK (1992))
Compound class:
Synthetic organic
Comment: Acetylcysteine is a prodrug for L-cysteine synthesis, and L-cysteine is a precursor to the biologic antioxidant glutathione. Hence adminstration of acetylcysteine replenishes glutathione stores.
|
|
No information available. |
Summary of Clinical Use ![]() |
Acetylcysteine is used to help prevent or reduce liver damage caused by acetaminophen (paracetamol) overdose. The EMA has designated acetylcysteine as an orphan drug for the treatment of pseudomyxoma peritonei (2018), where it is expected to dissolve mucus in the lungs so making it easier to clear. Acetylcysteine has been used for this action in patients with cystic fibrosis, but its efficacy in this condition has been questioned [2]. It is also indicated for the relief of dry eye syndromes associated with deficient tear secretion, impaired or abnormal mucus production (i.e. applied topically as eye drops as artificial tears with mucolytic and lubricant properties) |
External links ![]() |
For extended ADME data see the following: Electronic Medicines Compendium (eMC) |